Urticarial vasculitis in a COVID-19 recovered patient.
Identifieur interne : 000D04 ( Main/Corpus ); précédent : 000D03; suivant : 000D05Urticarial vasculitis in a COVID-19 recovered patient.
Auteurs : Soheila Nasiri ; Sahar Dadkhahfar ; Hajar Abasifar ; Nafiseh Mortazavi ; Mehdi GheisariSource :
- International journal of dermatology [ 1365-4632 ] ; 2020.
English descriptors
- KwdEn :
- Azithromycin (therapeutic use), COVID-19 (complications), COVID-19 (diagnosis), COVID-19 (drug therapy), COVID-19 (immunology), Drug Therapy, Combination (MeSH), Female (MeSH), Histamine Antagonists (therapeutic use), Humans (MeSH), Hydroxychloroquine (therapeutic use), Middle Aged (MeSH), Recurrence (MeSH), SARS-CoV-2 (immunology), SARS-CoV-2 (isolation & purification), Skin (blood supply), Skin (immunology), Skin (pathology), Treatment Outcome (MeSH), Urticaria (diagnosis), Urticaria (drug therapy), Urticaria (immunology), Urticaria (pathology), Vasculitis, Leukocytoclastic, Cutaneous (diagnosis), Vasculitis, Leukocytoclastic, Cutaneous (drug therapy), Vasculitis, Leukocytoclastic, Cutaneous (immunology), Vasculitis, Leukocytoclastic, Cutaneous (pathology).
- MESH :
- chemical , therapeutic use : Azithromycin, Histamine Antagonists, Hydroxychloroquine.
- blood supply : Skin.
- complications : COVID-19.
- diagnosis : COVID-19, Urticaria, Vasculitis, Leukocytoclastic, Cutaneous.
- drug therapy : COVID-19, Urticaria, Vasculitis, Leukocytoclastic, Cutaneous.
- immunology : COVID-19, SARS-CoV-2, Skin, Urticaria, Vasculitis, Leukocytoclastic, Cutaneous.
- isolation & purification : SARS-CoV-2.
- pathology : Skin, Urticaria, Vasculitis, Leukocytoclastic, Cutaneous.
- Drug Therapy, Combination, Female, Humans, Middle Aged, Recurrence, Treatment Outcome.
DOI: 10.1111/ijd.15112
PubMed: 32880937
PubMed Central: PMC7436580
Links to Exploration step
pubmed:32880937Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Urticarial vasculitis in a COVID-19 recovered patient.</title><author><name sortKey="Nasiri, Soheila" sort="Nasiri, Soheila" uniqKey="Nasiri S" first="Soheila" last="Nasiri">Soheila Nasiri</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Dadkhahfar, Sahar" sort="Dadkhahfar, Sahar" uniqKey="Dadkhahfar S" first="Sahar" last="Dadkhahfar">Sahar Dadkhahfar</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Abasifar, Hajar" sort="Abasifar, Hajar" uniqKey="Abasifar H" first="Hajar" last="Abasifar">Hajar Abasifar</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mortazavi, Nafiseh" sort="Mortazavi, Nafiseh" uniqKey="Mortazavi N" first="Nafiseh" last="Mortazavi">Nafiseh Mortazavi</name><affiliation><nlm:affiliation>Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Gheisari, Mehdi" sort="Gheisari, Mehdi" uniqKey="Gheisari M" first="Mehdi" last="Gheisari">Mehdi Gheisari</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32880937</idno><idno type="pmid">32880937</idno><idno type="doi">10.1111/ijd.15112</idno><idno type="pmc">PMC7436580</idno><idno type="wicri:Area/Main/Corpus">000D04</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000D04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Urticarial vasculitis in a COVID-19 recovered patient.</title><author><name sortKey="Nasiri, Soheila" sort="Nasiri, Soheila" uniqKey="Nasiri S" first="Soheila" last="Nasiri">Soheila Nasiri</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Dadkhahfar, Sahar" sort="Dadkhahfar, Sahar" uniqKey="Dadkhahfar S" first="Sahar" last="Dadkhahfar">Sahar Dadkhahfar</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Abasifar, Hajar" sort="Abasifar, Hajar" uniqKey="Abasifar H" first="Hajar" last="Abasifar">Hajar Abasifar</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Mortazavi, Nafiseh" sort="Mortazavi, Nafiseh" uniqKey="Mortazavi N" first="Nafiseh" last="Mortazavi">Nafiseh Mortazavi</name><affiliation><nlm:affiliation>Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author><author><name sortKey="Gheisari, Mehdi" sort="Gheisari, Mehdi" uniqKey="Gheisari M" first="Mehdi" last="Gheisari">Mehdi Gheisari</name><affiliation><nlm:affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of dermatology</title><idno type="eISSN">1365-4632</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (therapeutic use)</term><term>COVID-19 (complications)</term><term>COVID-19 (diagnosis)</term><term>COVID-19 (drug therapy)</term><term>COVID-19 (immunology)</term><term>Drug Therapy, Combination (MeSH)</term><term>Female (MeSH)</term><term>Histamine Antagonists (therapeutic use)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Middle Aged (MeSH)</term><term>Recurrence (MeSH)</term><term>SARS-CoV-2 (immunology)</term><term>SARS-CoV-2 (isolation & purification)</term><term>Skin (blood supply)</term><term>Skin (immunology)</term><term>Skin (pathology)</term><term>Treatment Outcome (MeSH)</term><term>Urticaria (diagnosis)</term><term>Urticaria (drug therapy)</term><term>Urticaria (immunology)</term><term>Urticaria (pathology)</term><term>Vasculitis, Leukocytoclastic, Cutaneous (diagnosis)</term><term>Vasculitis, Leukocytoclastic, Cutaneous (drug therapy)</term><term>Vasculitis, Leukocytoclastic, Cutaneous (immunology)</term><term>Vasculitis, Leukocytoclastic, Cutaneous (pathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term><term>Histamine Antagonists</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Skin</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>COVID-19</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>COVID-19</term><term>Urticaria</term><term>Vasculitis, Leukocytoclastic, Cutaneous</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term><term>Urticaria</term><term>Vasculitis, Leukocytoclastic, Cutaneous</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>COVID-19</term><term>SARS-CoV-2</term><term>Skin</term><term>Urticaria</term><term>Vasculitis, Leukocytoclastic, Cutaneous</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Skin</term><term>Urticaria</term><term>Vasculitis, Leukocytoclastic, Cutaneous</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Recurrence</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32880937</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-4632</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of dermatology</Title><ISOAbbreviation>Int J Dermatol</ISOAbbreviation></Journal><ArticleTitle>Urticarial vasculitis in a COVID-19 recovered patient.</ArticleTitle><Pagination><MedlinePgn>1285-1286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijd.15112</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nasiri</LastName><ForeName>Soheila</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-1413-2453</Identifier><AffiliationInfo><Affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dadkhahfar</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4058-2562</Identifier><AffiliationInfo><Affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abasifar</LastName><ForeName>Hajar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortazavi</LastName><ForeName>Nafiseh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gheisari</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-1268-7412</Identifier><AffiliationInfo><Affiliation>Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Dermatol</MedlineTA><NlmUniqueID>0243704</NlmUniqueID><ISSNLinking>0011-9059</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006633">Histamine Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006633" MajorTopicYN="N">Histamine Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014581" MajorTopicYN="N">Urticaria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018366" MajorTopicYN="N">Vasculitis, Leukocytoclastic, Cutaneous</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>07</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32880937</ArticleId><ArticleId IdType="doi">10.1111/ijd.15112</ArticleId><ArticleId IdType="pmc">PMC7436580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e244-e245</Citation><ArticleIdList><ArticleId IdType="pubmed">32294273</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Allergy Clin North Am. 2004 May;24(2):183-213, vi</Citation><ArticleIdList><ArticleId IdType="pubmed">15120147</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2020 Jul;83(1):e57-e60</Citation><ArticleIdList><ArticleId IdType="pubmed">32339706</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Res. 2020 Jun;220:1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2018 May 29;9:1001</Citation><ArticleIdList><ArticleId IdType="pubmed">29910796</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452</Citation><ArticleIdList><ArticleId IdType="pubmed">32339344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000D04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32880937
|texte= Urticarial vasculitis in a COVID-19 recovered patient.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32880937" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |